Company intelligence / Profile preview

Panteleimon Life Science Consulting

Ownership: Private
Development stage: Other

Overview

Panteleimon Life Science Consulting is a life sciences consulting company led by Peter Golikov. The firm provides business and technical expertise to biopharmaceutical environments, including drug development support, business planning, IP portfolio management, grant applications, fundraising guidance, and general management for emerging life science companies and academic institutions. It specializes in helping universities market unlicensed technologies and supports early-stage biotech ventures with strategic advice.

Industry: Consulting

Partnerships

North American universitiesEmerging life science companies

Beyond the preview

Go deeper on Panteleimon Life Science Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Panteleimon Life Science Consulting.

Explore the full profile